Clinical Trial Update: Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the combination of entecavir and tenofovir for multi-drug resistant chronic hepatitis B; trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Yonsei University | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN